Hassan Thwaini

Can Wegovy reduce the risk of cardiovascular disease?

The diabetes-turned-weight-loss drug that has taken the world by storm in recent years, semaglutide, has been shown to reduce major adverse cardiac events by 20%.1 This was demonstrated in non-diabetic patients who were obese or overweight and had cardiovascular disease (CVD).

Is Mounjaro linked to fatigue?

Obesity, type 2 diabetes, and being overweight all share fatigue as a common factor. Treating these conditions should, theoretically, alleviate any symptoms of excessive tiredness. However, one of the treatments used to tackle obesity, Mounjaro (tirzepatide), may be linked to causing further fatigue in a small minority of people. According to a recently published study on Wegovy (a similar drug to Mounjaro),1 7% of participants experienced side effects, some of which felt more tired than usual.1

Looking at weight loss beyond the scales

Weight is a sensitive topic for many people, and getting to that optimal weight is much easier said than done. However, once you get onto the weight loss journey that suits your lifestyle and start seeing results, there’s way more to the benefits than meets the eye, from reducing your risk of serious complications to finding more energy to do the activities you love.

How to keep the weight off after stopping medication

New weight loss medicines such as Wegovy, Saxenda, and Mounjaro have had all the hype in recent years due to their ability to effectively promote rapid weight loss. However, when you hit a healthy weight, you may wish to cease the medication.

Weight fluctuations: why they happen and how to overcome them

There’s very little more frustrating in the world than stepping on the scale only to find that those two pounds you shed a week ago have come back with a vengeance, despite all your efforts to stick to a healthy routine.